EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea

Minsu Kim iD, Bo Ri Kim iD, Chong Won Choi iD, Sang Woong Youn iD

Lasers in Surgery and Medicine · 2026

DOI: 10.1002/lsm.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, 2026. Verfasst von Minsu Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Rosacea, Lasers, Dye, Doxycycline, Calcineurin Inhibitors. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Given that the therapeutic evidence for doxycycline in rosacea has predominantly been derived from studies on papulopustular rosacea (PPR), this study aimed to evaluate the efficacy and safety of combined oral doxycycline, topical calcineurin inhibitor (TCI), and pulsed dye laser (PDL) therapy in erythematotelangiectatic rosacea (ETR) and to identify clinical predictors of treatment response. Materials and Methods Medical photographs of patients with ETR treated with oral doxycycline, TCI, and two subsequent PDL sessions were retrospectively reviewed. Erythema on the right cheek was quantitatively measured using computer‐aided image analysis.

Results

Of the 79 included patients, 47 had the ETR subtype and 32 had the mixed ETR/PPR subtype. Erythema significantly improved after oral doxycycline and TCI treatment ( p < 0.001) and further PDL treatment ( p < 0.001). Particularly, in patients with moderate‐to‐severe ETR, background erythema improved to a level comparable to that observed in patients with mild ETR after treatment ( p = 0.307). Post‐treatment erythema did not differ by age ( p = 0.963) or Fitzpatrick skin type ( p = 0.277); however, it was significantly lower among males ( p = 0.008) and in patients without prior steroid treatment ( p = 0.046). No serious adverse events, including photosensitivity, were observed.

Conclusion

Combined oral doxycycline, TCI, and PDL therapy is effective and safe for ETR, especially in patients with higher severity. Prompt diagnosis and avoidance of steroid misuse may improve treatment responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaLasers, DyeDoxycyclineCalcineurin InhibitorsAnti-Bacterial AgentsLow-Level Light TherapyHumansMaleFemaleRetrospective StudiesAdministration, OralTreatment OutcomeMiddle AgedCombined Modality TherapyAdultAgedTacrolimusAdministration, Topical

Stichwörter der Autor:innen

computer‐aided image analysisdoxycyclinepulsed dye laserrosaceatopical calcineurin inhibitor

Substanzen

DoxycyclineCalcineurin InhibitorsAnti-Bacterial AgentsTacrolimus

Autor:innen und Institutionen

  • Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

ORCID-Profile: Minsu Kim, Bo Ri Kim, Chong Won Choi, Sang Woong Youn

Zitieren

APA

Kim, M., Kim, B. R., Choi, C. W., & Youn, S. W. (2026). Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.70109

Vancouver

Kim M, Kim BR, Choi CW, Youn SW. Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea. Lasers in Surgery and Medicine. 2026. doi:10.1002/lsm.70109

BibTeX
@article{Kim2026,
  author = {Kim, Minsu and Kim, Bo Ri and Choi, Chong Won and Youn, Sang Woong},
  title = {Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea},
  journal = {Lasers in Surgery and Medicine},
  year = {2026},
  doi = {10.1002/lsm.70109}
}
Kostenlos starten →